About this trial
Tremor is a symptom that has already been described in many case reports and case series concerning patients with Charcot-Marie-Tooth (CMT) disease. However, the pathophysiology of tremor in this condition remains largely unclear. It has also not been sufficiently investigated to what extent tremor in CMT patients constitutes a relevant impairment of quality of life.
This project focuses on a more detailed characterization of tremor in CMT patients using surface electromyography and accelerometer analysis, as well as the collection of individual clinical data, particularly regarding the symptom of tremor, in order to facilitate the characterization and etiological classification of the tremor. In addition, a questionnaire-based assessment will be conducted to capture the impact of tremor on activities of daily living and the associated burden in this specific patient cohort.
The entire data collection process will be supported by a clinical examination, which will be video-recorded by experienced neurologists to ensure more reliable analysis. This serves both the characterization of tremor and the illustration of its functional limitations. Where available, the data will be correlated with genetic variants to allow conclusions about possible genetic predispositions or disease progression. As a control group, CMT patients who have not yet reported a tremor will be included.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Clinical CMT Diagnosis / Anamnestically Healthy Control Group
Genetic confirmation of CMT in adult patients
Ability to achieve the outcome measure at baseline
Age between 18 and 65 years
Disqualifiers
Pregnancy or breastfeeding period
Other relevant neurological or psychiatric disorders, acute or in the past history
Presence of a serious previous internal disease
Trial population
CMT-patients and healthy controls
Trial design
Other
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Activities of Daily Living -Questionaire(ADL)
Assessment of Handicap - Questionaire
Fahn Tolosa Marin Rating Scale
Electrophysiological characterization of tremor using surface EMG and accelerometer analysis
Secondary outcomes
MDS-UPDRS Part III without Tremor
SARA Score
Sponsors and contacts
Click on the lead sponsor to view all of their trials.